Mochida PharmaceuticalMochida Pharmaceutical Co.,Ltd.4534東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Mochida Pharmaceutical FY ending Mar 2020 results

Mochida Pharmaceutical brought in ¥101.8B in revenue.

Out of every ¥100 of sales, about ¥9 is left as operating profit.

Where the money goes

For every ¥100 Mochida Pharmaceutical sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 51.0% → Operating margin 8.7% → Net margin 4.5%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第86期(2023/04/01－2024/03/31)
ID S100TRAN2024-06-27Open
EDINET (FSA Japan)
有価証券報告書－第84期(令和3年4月1日－令和4年3月31日)
ID S100OI5J2022-06-29Open
EDINET (FSA Japan)
有価証券報告書－第83期(令和2年4月1日－令和3年3月31日)
ID S100LOG52021-06-29Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.